238 related articles for article (PubMed ID: 24676905)
1. VER-155008, a small molecule inhibitor of HSP70 with potent anti-cancer activity on lung cancer cell lines.
Wen W; Liu W; Shao Y; Chen L
Exp Biol Med (Maywood); 2014 May; 239(5):638-45. PubMed ID: 24676905
[TBL] [Abstract][Full Text] [Related]
2. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
[TBL] [Abstract][Full Text] [Related]
3. Increased antileukemic effects in human acute myeloid leukemia by combining HSP70 and HSP90 inhibitors.
Reikvam H; Nepstad I; Sulen A; Gjertsen BT; Hatfield KJ; Bruserud Ø
Expert Opin Investig Drugs; 2013 May; 22(5):551-63. PubMed ID: 23586877
[TBL] [Abstract][Full Text] [Related]
4. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
Cavanaugh A; Juengst B; Sheridan K; Danella JF; Williams H
Oncotarget; 2015 Nov; 6(37):39821-38. PubMed ID: 26556859
[TBL] [Abstract][Full Text] [Related]
6. Visualizing and Quantifying the Effect of the Inhibition of HSP70 on Breast Cancer Cells Based on Laser Scanning Microscopy.
Yu B; Yang H; Zhang X; Li H
Technol Cancer Res Treat; 2018 Jan; 17():1533033818785274. PubMed ID: 30175665
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein antagonists in early stage clinical trials for NSCLC.
Hendriks LEL; Dingemans AC
Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158
[TBL] [Abstract][Full Text] [Related]
8. Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC).
Jeong CH; Park HB; Jang WJ; Jung SH; Seo YH
Bioorg Med Chem Lett; 2014 Jan; 24(1):224-7. PubMed ID: 24345447
[TBL] [Abstract][Full Text] [Related]
9. Functional inhibition of heat shock protein 70 by VER-155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism.
Sakai K; Inoue M; Mikami S; Nishimura H; Kuwabara Y; Kojima A; Toda M; Ogawa-Kobayashi Y; Kikuchi S; Hirata Y; Mikami-Saito Y; Kyoyama H; Moriyama G; Shiibashi M; Seike M; Gemma A; Uematsu K
Thorac Cancer; 2021 Feb; 12(4):491-503. PubMed ID: 33319489
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins.
Lee KH; Lee JH; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
Cancer Sci; 2011 Jul; 102(7):1388-95. PubMed ID: 21453385
[TBL] [Abstract][Full Text] [Related]
11. Regulating the cytoprotective response in cancer cells using simultaneous inhibition of Hsp90 and Hsp70.
Wang Y; McAlpine SR
Org Biomol Chem; 2015 Feb; 13(7):2108-16. PubMed ID: 25526223
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of methylene blue via inhibition of heat shock protein 70.
Sanchala D; Bhatt LK; Pethe P; Shelat R; Kulkarni YA
Biomed Pharmacother; 2018 Nov; 107():1037-1045. PubMed ID: 30257315
[TBL] [Abstract][Full Text] [Related]
13. Targeting HSP70 and GRP78 in canine osteosarcoma cells in combination with doxorubicin chemotherapy.
Asling J; Morrison J; Mutsaers AJ
Cell Stress Chaperones; 2016 Nov; 21(6):1065-1076. PubMed ID: 27631331
[TBL] [Abstract][Full Text] [Related]
14. Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma.
Huang L; Wang Y; Bai J; Yang Y; Wang F; Feng Y; Zhang R; Li F; Zhang P; Lv N; Lei L; Hu J; He A
Cell Stress Chaperones; 2020 Mar; 25(2):357-367. PubMed ID: 32026316
[TBL] [Abstract][Full Text] [Related]
15. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
Håvik B; Bramham CR
Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
[TBL] [Abstract][Full Text] [Related]
16. Induction of the heat shock response in Arabidopsis by heat shock protein 70 inhibitor VER-155008.
Matsuoka E; Kato N; Hara M
Funct Plant Biol; 2019 Sep; 46(10):925-932. PubMed ID: 31217072
[TBL] [Abstract][Full Text] [Related]
17. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW
Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
[TBL] [Abstract][Full Text] [Related]
18. Targeting heat shock proteins in cancer.
Jego G; Hazoumé A; Seigneuric R; Garrido C
Cancer Lett; 2013 May; 332(2):275-85. PubMed ID: 21078542
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
[TBL] [Abstract][Full Text] [Related]
20. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.
Powers MV; Clarke PA; Workman P
Cancer Cell; 2008 Sep; 14(3):250-62. PubMed ID: 18772114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]